# Bed Rest, Alternate Daily Fasting and Incretin Effect

> **NCT02134860** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 20 (actual)

## Conditions studied

- Metabolic Syndrome
- Type 2 Diabetes
- Critical Illness

## Interventions

- **OTHER:** Bed rest
- **OTHER:** OGTT
- **OTHER:** IVGTT
- **OTHER:** Cognitive testing
- **OTHER:** Muscle and fat biopsies
- **OTHER:** Dual-energy X-ray Absorptiometry (DXA) scan
- **OTHER:** MRI

## Key facts

- **NCT ID:** NCT02134860
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02134860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02134860, "Bed Rest, Alternate Daily Fasting and Incretin Effect". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02134860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*